معرفی
Aleksi Tornio is a researcher at the Faculty of Medicine, University of Helsinki, with a focus on clinical pharmacology and pharmacogenetics. He supervises doctoral students in Clinical Research and Drug Research programs, contributing to projects like TransporterPGx (ERC-funded) and studies on enzyme inhibition mechanisms.
- Clinical Pharmacology and Drug Therapy
- Pharmacogenetics
- Medical Biotechnology
His research explores drug metabolism variability through genetic factors, particularly involving cytochrome P450 enzymes and transporters like SLCO1B1. Recent work includes genome-wide association studies on statins and antiplatelet agents, aiming to improve pharmacogenetic testing applications.
Selected scientific output trends show consistent contributions to pharmacokinetics modeling, enzyme-substrate interactions, and personalized drug therapy. He received a Best Poster Award in 2019 and actively participates in conference organization and expert presentations.
- 2025: Phenotyping tools for drug metabolizing enzymes
- 2024: Statin pharmacogenetics
- 2023: Drug transporter variability
Professional involvement includes membership in the Research Ethics Advisory Board (2019–2022) and collaborative projects across Finland's biomedical research networks.
